Tharimmune : Corporate Presentations
MarketScreener,
Unlocking Immunology for a Better Tomorrow Corporate Presentation Forward Looking Statements This presentation contains certain…
Unlocking Immunology for a Better Tomorrow Corporate Presentation Forward Looking Statements This presentation contains certain…
Phase 1 ex-US trial achieved primary objective of predictable pharmacokinetic profiling with favorable safety and tolerability…
Phase 1 ex-US trial achieved primary objective of predictable pharmacokinetic profiling with favorable safety and tolerability…